The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type

Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma

(2015) T. Kawai et al.   CLINICAL CANCER RESEARCH

Clinicopathologic Analysis of Combined Hepatocellular-Cholangiocarcinoma According to the Latest WHO Classification

(2013) Jun Akiba et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies

(2012) Mika Fujiwara et al.   CANCER CYTOPATHOLOGY

Clinicopathological and Prognostic Implications of Arginase Expression in Hepatocellular Carcinoma

(2012) Huahui Mao et al.   Clinical Laboratory

Immunohistochemical study of arginase 1 and 2 in various tissues of rats

(2011) Sungyoung Choi et al.   ACTA HISTOCHEMICA

Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13

(2011) Rachel F. Gabitass et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Expression of Keratin 19 Is Related to High Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation

(2011) Kaoru Tsuchiya et al.   ONCOLOGY

Arginase-1

(2010) Benjamin C. Yan et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Toward unraveling the complexity of simple epithelial keratins in human disease

(2009) M. Bishr Omary et al.   JOURNAL OF CLINICAL INVESTIGATION